Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06915311Recruiting

Danish Prognostic Research on Embryonic Diagnostics Involving Chromosomal Testing.

Role: collaborator

NCT04705935Completed

Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth

Role: collaborator

NCT04584047Not ApplicableCompleted

Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing

Role: collaborator

NCT05453474Not ApplicableCompleted

Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling

Role: collaborator

All 4 trials loaded